Followers | 3167 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Monday, April 29, 2019 12:02:26 PM
And yesssssssss of course VYST not releasing any news for 53 days and counting could mean anything...but the point I was making was simple, if VYST was just like the over-whelming majority of its OTC peers, then it would still be drowning in toxic 3rd party noteholder dilution and perpetual R&D...2 things VYST is no longer stuck in as last quarters soft launch of the Vytex CLOUD bed-in-a-box and associated bedding products launched across multiple mainstream retailers clearly reflects.
And since the over-whelming majority of dilutive turd OTC plays stuck in perpetual R&D phases can never attract let alone receive any friendly private placement financing period, let alone ever completely eliminate all 3rd party toxic noteholder dilution...it's a great sign that VYST has in fact eliminated all 3rd party noteholders and hasn't had to pump out news every week over the past 7+ weeks like the over-whelming majority of their dilutive OTC market peers would've been doing when they're drowing in 3rd party toxic noteholders and stuck in their perpetual R&D phases.
It's also never laughable when any funders invest in a PubCo and are willing to do so for Restricted 144 shares only, as it proves that those said funders believe in the future worth of said shares, otherwise they wouldn't purchase Restricted 144 shares in the 1st place, let alone would they be willing to pay a premium strike price for them.
Recent VYST News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 12:36:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/21/2024 05:30:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/06/2024 09:17:28 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:55:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 09:23:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM